The Latest
CCAGW Urges Missouri Senate Leadership to Oppose HB 1677
HB 1677 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers.
Connecticut to Increase CON law Fees by 4,900 Percent
Connecticut should avoid higher fees for CON laws that increase costs and limit access to quality healthcare.
CCAGW Joins Coalition Supporting Accelerated Depreciation for All Structures
This bill will make the tax code more efficient and will help grow the economy.
Next Wave of Mid-band Spectrum Scheduled for Auction
Federal Communications Commission announces schedule for auctioning the 2.5 GHz spectrum licenses.
CCAGW Urges Kentucky Senate Appropriations and Revenue Committee to Oppose HB 457
HB 457 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers.
Only Taxpayers Know How Much They Really Owe in Taxes
Taxpayers have information only they know to fill out their tax returns; the IRS should never do that for them.
Transparency is Needed Before More COVID-19 Aid is Approved
Congress and the rest of the federal government must increase transparency for taxpayers
CCAGW Joins Coalition Opposing Expansion of Durbin Amendment to Credit Cards
Expansion of the Durbin Amendment to credit cards would harm consumers and small businesses
The Time Is Now for U.S. Energy Independence
U.S. energy independence will stabilize and lower fuel prices for Americans suffering under record high inflation.
CCAGW Urges Missouri House of Representatives to Oppose HB 1677
HB 1677 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmaceutical benefit managers.
CCAGW Urges Alaska House Judiciary Committee to Oppose HB 159
HB 159 will fail to achieve its objective to protect consumer privacy.
CCAGW Urges House of Representatives to Oppose H.R. 7007
March 16, 2022 U.S. House of Representatives Washington, D.C. 20515 Dear Representative,